Go to interview with Robert W Carlson, MD
Go to interview with Clifford Hudis, MD
Go to interview with Anne P O’Connor, RN, MSN, AOCN
Go to interview with Ms B
Go to interview with Ms C
 
 
 
To listen to individual tracks now, click on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
 
     
Carlson, MD Robert W Carlson, MD
Professor of Medicine
Division of Oncology and
Stanford Medical Informatics
Stanford University Medical Center
Stanford, California
 		 
  Click here to download the entire interview  
Track 1 Rationale for ovarian suppression with an LHRH agonist
Track 2 Clinical trial evaluating anastrozole with goserelin for premenopausal patients with metastatic
breast cancer
Track 3 Efficacy of monthly versus every three-month administration of an LHRH agonist
Track 4 Selection of endocrine therapy for hormone receptor-positive, metastatic breast cancer
Track 5 EFECT: Fulvestrant versus exemestane for advanced breast cancer following progression on a nonsteroidal aromatase inhibitor
Track 6 TAnDEM: Anastrozole with or without trastuzumab for estrogen receptor-positive, HER2-overexpressing, metastatic breast cancer Arrow
Track 7 Nanoparticle albumin-bound (nab) paclitaxel versus paclitaxel in the treatment of metastatic
breast cancer		 Arrow
Track 8 Risk-benfit profile of nab paclitaxel Arrow
Track 9 Clinical trials evaluating bevacizumab in the metastatic setting Arrow
Track 10 Selection of chemotherapy for a patient with triple-negative breast cancer and multiple bone metastases Arrow
Track 11 Quality-of-life issues and side effects associated with the use of bevacizumab Arrow
Track 12 Dosing and scheduling of capecitabine for metastatic disease Arrow
Track 13 Counseling patients with newly diagnosed metastatic disease Arrow
Track 14 Supportive measures for oncology healthcare professionals Arrow
     
Hudis, MD Clifford Hudis, MD
Chief, Breast Cancer Medicine Service
Solid Tumor Division
Memorial Sloan-Kettering Cancer Center
New York, New York
  
  Click here to download the entire interview  
Track 1 Mechanism of action of endocrine therapies used in the treatment of breast cancer
Track 2 Consistencies in clinical trials comparing aromatase inhibitors to tamoxifen in the adjuvant setting
Track 3 Management of arthralgias associated with the use of aromatase inhibitors
Track 4 Sequence and duration of endocrine therapies in the adjuvant setting
Track 5 Impact of aromatase inhibitors on bone mineral density
Track 6 Endocrine therapy for premenopausal women with breast cancer
Track 7 Optimal duration of adjuvant endocrine therapy
Track 8 Delayed endocrine therapy in the adjuvant setting
Track 9 Clinical indications for using the Oncotype DX™ assay
Track 10 Efficacy of adjuvant docetaxel/cyclophosphamide versus doxorubicin/cyclophosphamide
Track 11 Tolerability of docetaxel/cyclophosphamide versus doxorubicin/cyclophosphamide
Track 12 Adjuvant therapy for early HER2-positive breast cancer
Track 13 Use of trastuzumab for patients with small, estrogen receptor-positive tumors
Track 14 Selection of chemotherapy for combination with trastuzumab in the adjuvant setting
Track 15 Optimal duration of trastuzumab therapy
Track 16 Cardiotoxicities associated with trastuzumab
     
O'Connor, MD Anne P O’Connor, RN, MSN, AOCN
Clinical Nurse Coordinator — Oncology
Lombardi Comprehensive Cancer Center
Washington, DC
  
  Click here to download the entire interview  
Track 1 Counseling patients about the role of adjuvant chemotherapy Audio
Track 2 Utility of the Oncotype DX assay in treatment decision-making
Track 3 Patient education about toxicities secondary to tamoxifen Audio
Track 4 Educating patients about side effects associated with aromatase inhibitors Audio
Track 5 Monitoring cardiac status in patients on adjuvant trastuzumab Audio
Track 6 Patient compliance with oral endocrine therapies Audio
Track 7 Tolerability of chemotherapy and its impact on quality of life Audio
Track 8 Providing support for patients with newly diagnosed metastatic disease
Track 9 Addressing the concerns of patients with advanced breast cancer

     
  Ms B
  
  Click here to download the entire interview  
Track 1 An experienced oncology nurse receives cytotoxic chemotherapy for breast cancer
Track 2 Impact of the patient’s cancer experience on her role as a nurse
Track 3 Severe nausea and vomiting associated with AC therapy
Track 4 Change in perspective after breast cancer
Track 5 Patient’s advice to women diagnosed with breast cancer
     
  Ms C
  
  Click here to download the entire interview  
Track 1 Diagnosis of early breast cancer in a 63-year-old neurology technician
Track 2 Clinical use of Oncotype DX

 

 
Home Terms of Use/Disclaimer | Privacy Policy | Hardware/Software Requirements
Copyright © 2007 Research To Practice, All Rights Reserved		 Contact us